[go: up one dir, main page]

DE69434084D1 - Diagnostische anwendungen von hydrazinoadenosine - Google Patents

Diagnostische anwendungen von hydrazinoadenosine

Info

Publication number
DE69434084D1
DE69434084D1 DE69434084T DE69434084T DE69434084D1 DE 69434084 D1 DE69434084 D1 DE 69434084D1 DE 69434084 T DE69434084 T DE 69434084T DE 69434084 T DE69434084 T DE 69434084T DE 69434084 D1 DE69434084 D1 DE 69434084D1
Authority
DE
Germany
Prior art keywords
hydrazinoadenosine
diagnostic applications
diagnostic
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69434084T
Other languages
English (en)
Other versions
DE69434084T2 (de
Inventor
A Mcafee
Geoffrey Allan
J Barrett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aderis Pharmaceuticals Inc
Original Assignee
Aderis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aderis Pharmaceuticals Inc filed Critical Aderis Pharmaceuticals Inc
Publication of DE69434084D1 publication Critical patent/DE69434084D1/de
Application granted granted Critical
Publication of DE69434084T2 publication Critical patent/DE69434084T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69434084T 1993-09-10 1994-08-05 Diagnostische verwendungen von hydrazinoadenosinen Expired - Lifetime DE69434084T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/119,774 US5477857A (en) 1993-09-10 1993-09-10 Diagnostic uses of hydrazinoadenosines
US119774 1993-09-10
PCT/US1994/008847 WO1995007049A1 (en) 1993-09-10 1994-08-05 Diagnostic uses of hydrazinoadenosines

Publications (2)

Publication Number Publication Date
DE69434084D1 true DE69434084D1 (de) 2004-11-25
DE69434084T2 DE69434084T2 (de) 2005-11-03

Family

ID=22386314

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69434084T Expired - Lifetime DE69434084T2 (de) 1993-09-10 1994-08-05 Diagnostische verwendungen von hydrazinoadenosinen

Country Status (7)

Country Link
US (1) US5477857A (de)
EP (1) EP0727959B1 (de)
JP (1) JP4176827B2 (de)
AU (1) AU692461B2 (de)
CA (1) CA2170879C (de)
DE (1) DE69434084T2 (de)
WO (1) WO1995007049A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6102904A (en) * 1995-07-10 2000-08-15 Interventional Technologies, Inc. Device for injecting fluid into a wall of a blood vessel
US5873852A (en) * 1995-07-10 1999-02-23 Interventional Technologies Device for injecting fluid into a wall of a blood vessel
US6026317A (en) * 1998-02-06 2000-02-15 Baylor College Of Medicine Myocardial perfusion imaging during coronary vasodilation with selective adenosine A2 receptor agonists
US6210392B1 (en) 1999-01-15 2001-04-03 Interventional Technologies, Inc. Method for treating a wall of a blood vessel
US6695830B2 (en) * 1999-01-15 2004-02-24 Scimed Life Systems, Inc. Method for delivering medication into an arterial wall for prevention of restenosis
USRE47351E1 (en) 1999-06-22 2019-04-16 Gilead Sciences, Inc. 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
US6403567B1 (en) 1999-06-22 2002-06-11 Cv Therapeutics, Inc. N-pyrazole A2A adenosine receptor agonists
US6339716B1 (en) * 1999-09-24 2002-01-15 Bioenergy Inc. Method for determining viability of a myocardial segment
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
EP1841355A4 (de) * 2005-01-12 2012-09-05 King Pharmaceuticals Res & Dev Verfahren zur erkennung myokardialer dysfunktion bei patienten mit früherem leiden an asthma oder bronchospasmen
PT1989214T (pt) 2006-02-03 2016-09-22 Gilead Sciences Inc Processo para preparar um agonista de recetor de adenosina a2a e polimorfos do mesmo
JP2010515081A (ja) * 2007-01-03 2010-05-06 ギリアード・パロ・アルト・インコーポレイテッド 心筋灌流画像化
CA2716501A1 (en) * 2008-02-29 2009-09-03 King Pharmaceuticals Research And Development, Inc. Crystal forms of 2-{2-[(cyclohexyl)methylene]hydrazino}adenosine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284834A (en) * 1985-03-29 1994-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same
US4824660A (en) * 1985-06-06 1989-04-25 Paul S. Angello Method of determining the viability of tissue in an organism
US5063233A (en) * 1986-11-14 1991-11-05 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists
US5066655A (en) * 1987-04-24 1991-11-19 Whitby Research, Inc. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US5290782A (en) * 1989-09-01 1994-03-01 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
GB9111130D0 (en) * 1991-05-23 1991-07-17 Ici Plc Azole derivatives
US5278150A (en) * 1992-04-24 1994-01-11 Whitby Research, Inc. 2-hydrazoadenosines and their utility for the treatmeat of vascular conditions

Also Published As

Publication number Publication date
CA2170879A1 (en) 1995-03-16
EP0727959B1 (de) 2004-10-20
CA2170879C (en) 2007-07-17
WO1995007049A1 (en) 1995-03-16
JPH09502435A (ja) 1997-03-11
DE69434084T2 (de) 2005-11-03
US5477857A (en) 1995-12-26
EP0727959A1 (de) 1996-08-28
JP4176827B2 (ja) 2008-11-05
AU7451994A (en) 1995-03-27
EP0727959A4 (de) 2000-11-08
AU692461B2 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
DE69429306D1 (de) Spritzenaufbau
DE69413765D1 (de) An die Einführung von chirurgischen Instrumenten anpassbare Dichtung
DE69418220D1 (de) Befestigung von Biomolekülen
PT1028198E (pt) Elemento de fundacao de estrutura de construcao
DE69405141D1 (de) Vorhangbefestigungsvorrichtung und Zusammenbau von Vorhangbefestigungsvorrichtungen
DE69434084D1 (de) Diagnostische anwendungen von hydrazinoadenosine
DE69400036D1 (de) Reinigung von Pentafluorethan.
NO965564D0 (no) Medisinsk anvendelse av bromelain
DE69405329D1 (de) Reinigung von 2-Methylglutaro- oder Adiponitril
DE69421273D1 (de) Kristallisation von 2,6-dimethylnaphthalin
FI954422L (fi) Ferroseenin käyttö
FI944280A0 (fi) Mingreenin vastaisia indolyylialkyyli-pyridinyyli- ja-pyrimidinyyli-piperatsiinien syklobuteenidionijohdannaisia
NO963482D0 (no) Medisinsk anvendelse av bromelain
DE59403207D1 (de) Herstellung von Perfluoralkanen
NO931399D0 (no) Anvendelse av naturstein
DK36193D0 (da) Fremgangsmaade
DE69417915D1 (de) Reinigung von uranhexafluorid
KR950022116U (ko) 모니터의 케이스 조립장치
ITMI931785A1 (it) Valilamidi di 7alfa-amino-1, 1-dioxo-cefem
DE69325271D1 (de) Hydrosilylierung von fullarenen
SE9301995D0 (sv) Ny medicinsk anvaendning
KR950013629U (ko) 제함기의 제함장치
BR9301967A (pt) Aromatizador de ambientes
KR950001288U (ko) 제화미싱의 구조
FI955597A (fi) Ristiinkierretyn punoskoosteen valmistaminen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition